Author Correction: Hepatocellular carcinoma

Affiliations

• ¹ Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. josep.llovet@mssm.edu.
• ² Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Catalonia, Spain. josep.llovet@mssm.edu.
• ³ Institució Catalana d'Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. josep.llovet@mssm.edu.
• ⁴ Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA.
• ⁵ Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁶ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
• ⁷ The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University of Jerusalem, Jerusalem, Israel.
• ⁸ White Plains Hospital Center for Cancer Care, Montefiore Health, White Plains, NY, USA.
• ⁹ Department of Radiology, Pisa University School of Medicine, Pisa, Italy.
• ¹⁰ Department of Radiology, Miami Cancer Insitute, Miami, FL, USA.
• ¹¹ The University of Tokyo, Department of Gastroenterology, Tokyo, Japan.
• ¹² Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, USPC, Université Paris Descartes, Université Paris Diderot, Paris, France.
• ¹³ Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
• ¹⁴ Department of Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.